首页 | 本学科首页   官方微博 | 高级检索  
     


Early and effective treatment of KCNQ2 encephalopathy
Authors:Tiziana Pisano  Adam L. Numis  Sinéad B. Heavin  Sarah Weckhuysen  Marco Angriman  Arvid Suls  Barbara Podesta  Ronald L. Thibert  Kevin A. Shapiro  Renzo Guerrini  Ingrid E. Scheffer  Carla Marini  Maria Roberta Cilio
Affiliation:1. Neurology Unit and Laboratories, A. Meyer Children's Hospital, Florence, Italy;2. Department of Neurology, University of California, San Francisco, San Francisco, California, U.S.A;3. Departments of Medicine and Paediatrics, Florey Institute, Austin Health and Royal Children's Hospital, University of Melbourne, Melbourne, Victoria, Australia;4. Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium;5. Laboratory of Neurogenetics, Institute Born‐Bunge, University of Antwerp, Antwerp, Belgium;6. Central Hospital of Bolzano, Bolzano, Italy;7. Child Neurology and Psychiatry Unit, S. Croce and S. Carlo Hospital, Cuneo, Italy;8. Pediatric Epilepsy Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A;9. University of Florence, Florence, Italy;10. Department of Pediatrics, University of California San Francisco, San Francisco, California, U.S.A
Abstract:
Keywords:Epilepsy  KCNQ2 encephalopathy  Antiepileptic drug treatment
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号